Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis

Journal of Clinical Periodontology

Volumn 38, Issue 11, 2011, Pages 1029-1036

  Yuan, Huaiping ^a   Gupte, Rohit ^a   Zelkha, Sami ^a   Amar, Salomon ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

bone loss; experimental periodontitis; inflammation; Kavain; osteoprotegerin Fc; receptor activator of nuclear factor kappa B ligand antagonist; receptor activator of nuclear factor kappa B Fc

Indexed keywords

CCL2 PROTEIN, MOUSE; HYBRID PROTEIN; INTERLEUKIN 6; KAWAIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PYRONE DERIVATIVE; RANK FC; RANK-FC; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; DRUG ANTAGONISM; MALE; METABOLISM; MOUSE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RANDOMIZATION;

ALVEOLAR BONE LOSS; ANIMALS; CHEMOKINE CCL2; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; OSTEOPROTEGERIN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PYRONES; RANDOM ALLOCATION; RANK LIGAND; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054074027     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2011.01780.x     Document Type: Article

References (35)

1. Albandar, J,. (2005) Epidemiology and risk factors of periodontal diseases. Dental Clinics of North America 49, 517-532, v. (Pubitemid 40835771)
2. Amar, S., Zhou, Q., Shaik-Dasthagirisaheb, Y., &, Leeman, S., (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proceedings of the National Academy of Sciences of the United States of America 104, 20466-20471.
3. Assuma, R., Oates, T., Cochran, D., Amar, S., &, Graves, D. T., (1998) IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. The journal of immunology 160, 403-409. (Pubitemid 28116755)
4. Bielory, L., (2004) Complementary and alternative interventions in asthma, allergy, and immunology. Annals of allergy, asthma, immunology 93, S45-S54. (Pubitemid 39128485)
5. Cochran, D., (2008) Inflammation and bone loss in periodontal disease. Journal of Periodontology 79, 1569-1576.
6. Crotti, T., Smith, M., Hirsch, R., Soukoulis, S., Weedon, H., Capone, M., Ahern, M., &, Haynes, D., (2003) Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. Journal of Periodontal Research 38, 380-387. (Pubitemid 37465544)
7. Cummings, S., San Martin, J., McClung, M., Siris, E., Eastell, R., Reid, I.R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., Kutilek, S., Adami, S., Zanchetta, J., Libanati, C., Siddhanti, S., &, Christiansen, C,. (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England Journal of Medicine 361, 756-765.
8. D'Aiuto, F., Parkar, M., Andreou, G., Suvan, J., Brett, P. M., Ready, D., &, Tonetti, M. S,. (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. Journal of Dental Research 83, 156-160. (Pubitemid 41713801)
9. Dias, I. H., Matthews, J. B., Chapple, I. L., Wright, H. J., Dunston, C. R., &, Griffiths, H. R., (2011) Activation of the neutrophil respiratory burst by plasma from periodontitis patients is mediated by pro-inflammatory cytokines. Journal of Clinical Periodontology 38, 1-7.
10. Eke, P. I., Thornton-Evans, G. O., Wei, L., Borgnakke, W. S., &, Dye, B. A., (2010) Accuracy of NHANES periodontal examination protocols. Journal of Dental Research 89, 1208-1213.
11. Ekuni, D., Tomofuji, T., Irie, K., Kasuyama, K., Umakoshi, M., Azuma, T., Tamaki, N., Sanbe, T., Endo, Y., Yamamoto, T., Nishida, T., &, Morita, M., (2010) Effects of periodontitis on aortic insulin resistance in an obese rat model. Laboratory Investigation 90, 348-359.
12. Emery, J. G, McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., Dodds, R. A., James, I. E., Rosenberg, M., Lee, J. C., &, Young, P. R., (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. Journal of Biological Chemistry 273, 14363-14367. (Pubitemid 28319153)
13. Folmer, F., Blasius, R., Morceau, F., Tabudravu, J., Dicato, M., Jaspars, M., &, Diederich, M,. (2006) Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochemical Pharmacology 71, 1206-1218. (Pubitemid 43357901)
14. Jin, Q., Cirelli, J., Park, C., Sugai, J., Taba, M., Kostenuik, P., &, Giannobile, W. V., (2007) RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. Journal of Periodontology 78, 1300-1308.
15. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., &, Boyle, W. J., (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176. (Pubitemid 28180851)
16. Li, C., &, Amar, S., (2007) Morphometric, histomorphometric, and microcomputed tomographic analysis of periodontal inflammatory lesions in a murine model. Journal of Periodontology 78, 1120-1128.
17. Mathews, J. M., Etheridge, A. S., Valentine, J. L., Black, S. R., Coleman, D. P., Patel, P., So, J., &, Burka, L. T., (2005) Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro. Drug Metabolism and Disposition 33, 1555-1563. (Pubitemid 41324005)
18. Miller, R. E., Branstetter, D., Armstrong, A., Kennedy, B., Jones, J., Cowan, L., Bussiere, J., &, Dougall, W. C., (2007) Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection. Journal of Immunology 179, 266-274. (Pubitemid 46986542)
19. Neumann, T., Oelzner, P., Petrow, P. K., Thoss, K., Hein, G., Stein, G., &, Bräuer, R., (2006) Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis. Inflammation Research 55, 32-39. (Pubitemid 43142809)
20. Ominsky, M. S., Li, X., Asuncion, F. J., Barrero, M., Warmington, K. S., Dwyer, D., Stolina, M., Geng, Z., Grisanti, M., Tan, H. L., Corbin, T., McCabe, J., Simonet, W. S., Ke, H. Z., &, Kostenuik, P. J,. (2008) RANKL inhibition with osteoprotegrin increases bone strength by improving cortical and trabecular architecture in overectomized rats. Journal of Bone and Mineral Research 23, 672.
21. Oyajobi, B. O., Anderson, D. M., Traianedes, K., Williams, P. J., Yoneda, T., &, Mundy, G. R., (2001) Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy. Cancer Research 61, 2572-2578. (Pubitemid 32685841)
22. Oz, H. S., &, Puleo, D. A., (2011) Animal models for periodontal disease. Journal of Biomedicine and Biotechnology 2011, 754857.
23. Passoja, A., Puijola, I., Knuuttila, M., Niemela, O., Karttunen, R., Raunio, T., &, Tervonen, T., (2010) Serum levels of interleukin-10 and tumour necrosis factor-alpha in chronic periodontitis. Journal of Clinical Periodontology 37, 881-887.
24. Pittler, M. H., &, Edzard, E., (2001) Kava extract for treating anxiety. Cochrane Database of Systematic Reviews CD003383.
25. Pollastri, M., Whitty, A., Merrill, J., Tang, X., Ashton, T., &, Amar, S., (2009) Identification and characterization of kava-derived compounds mediating TNF-alpha suppression. Chemical biology drug design 74, 121-128.
26. Preshaw, P. M., &, Taylor, J. J., (2011) How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? Journal of Clinical Periodontology 38 (Suppl. 11), 60-84.
27. Sarris, J., &, Kavanagh, D,. (2009) Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. Journal of alternative and complementary medicine 15, 827-836.
28. Scheinfeld, N., (2004) A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. Journal of Dermatological Treatment 15, 280-294. (Pubitemid 39423287)
29. Stolina, M., Guo, J., Faggioni, R., Brown, H., &, Senaldi, G., (2003) Regulatory effects of osteoprotegerin on cellular and humoral immune responses. Clinical Immunology 109, 347-354. (Pubitemid 38091454)
30. Verdrengh, M., Bokarewa, M., Ohlsson, C., Stolina, M., &, Tarkowski, A., (2010) RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. Bone 46, 752-758.
31. Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H. L., Steinman, R. M., &, Choi, Y., (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. Journal of Experimental Medicine 186, 2075-2080. (Pubitemid 28013694)
32. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N., &, Suda, T., (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America 95, 3597-3602.
33. Zelkha, S., Freilich, R., &, Amar, S,. (2010) Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontology 54, 207-221.
34. Zhang, X., Kohli, M., Zhou, Q., Graves, D., &, Amar, S., (2004) Short- and long-term effects of IL-1 and TNF antagonists on periodontal wound healing. The journal of immunology 173, 3514-3523. (Pubitemid 39142062)
35. Zi, X., &, Simoneau, A. R., (2005) Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Research 65, 3479-3486. (Pubitemid 40524635)